Patients accept therapy using embryonic stem cells for Parkinson's disease: a discrete choice experiment.

ABSTRACT:

Background

New disease-modifying ways to treat Parkinson's disease (PD) may soon become a reality with intracerebral transplantation of cell products produced from human embryonic stem cells (hESCs). The aim of this study was to assess what factors influence preferences of patients with PD regarding stem-cell based therapies to treat PD in the future.

Methods

Patients with PD were invited to complete a web-based discrete choice experiment to assess the importance of the following attributes: (i) type of treatment, (ii) aim of treatment, (iii) available knowledge of the different types of treatments, (iv) effect on symptoms, and (v) risk for severe side effects. Latent class conditional logistic regression models were used to determine preference estimates and heterogeneity i

SUBMITTER: Bywall KS 

PROVIDER: S-EPMC10571417 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature